THE RELATIONSHIP BETWEEN DEBRISOQUINE OXIDATION PHENOTYPE AND THE PHARMACOKINETICS AND PHARMACODYNAMICS OF PROPRANOLOL

被引：73

作者：

LENNARD, MS

JACKSON, PR

FREESTONE, S

TUCKER, GT

RAMSAY, LE

WOODS, HF

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 17卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1984.tb02403.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：679 / 685

页数：7

相关论文

共 22 条

[1] BAI SA, 1983, J PHARMACOL EXP THER, V224, P62
[2] CLEAVELAND CR, 1972, CLIN PHARMACOL THER, V13, P181
[3] PLASMA PROPRANOLOL LEVELS IN QUANTITATIVE ASSESSMENT OF BETA-ADRENERGIC BLOCKADE IN MAN
COLTART, DJ
SHAND, DG
[J]. BRITISH MEDICAL JOURNAL, 1970, 3 (5725) : 731 - &
[4] DAYER P, 1983, SCHWEIZ MED WSCHR, V113, P295
[5] DEFECTIVE HYDROXYLATION OF BUFURALOL ASSOCIATED WITH SIDE-EFFECTS OF THE DRUG IN POOR METABOLIZERS
DAYER, P
KUBLI, A
KUPFER, A
COURVOISIER, F
BALANT, L
FABRE, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) : 750 - 752
[6] PHARMACOLOGY OF 4-HYDROXYPROPRANOLOL, A METABOLITE OF PROPRANOLOL
FITZ GERALD, JD
ODONNELL, SR
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1971, 43 (01) : 222 - +
[7] LENNARD MS, 1983, NEW ENGL J MED, V308, P965
[8] DEFECTIVE METABOLISM OF METOPROLOL IN POOR HYDROXYLATORS OF DEBRISOQUINE
LENNARD, MS
SILAS, JH
FREESTONE, S
TREVETHICK, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) : 301 - 303
[9] OXIDATION PHENOTYPE - A MAJOR DETERMINANT OF METOPROLOL METABOLISM AND RESPONSE
LENNARD, MS
SILAS, JH
FREESTONE, S
RAMSAY, LE
TUCKER, GT
WOODS, HF
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) : 1558 - 1560
[10] LENNARD MS, 1983, PHARM INT, V4, P61